Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Agrez

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Australian & New Zealand Journal of Obstetrics & Gynaecology|March 31, 2026
An Immunomodulating Peptide With Potential to Counteract EndometriosisMichael Agrez
Journal for Immunotherapy of Cancer|May 20, 2026
Immune tolerance versus cancer surveillance: an ongoing challengeMichael Agrez
ANZ Journal of Surgery|September 24, 2004
Rectal cancer masquerading as an amoeboma: case report and review of the literatureMichael Agrez, Costa Karihaloo, Glenn Reeves, et al.
Biomaterials|January 10, 2025
Immune-modulating nanomedicines for enhanced drug delivery to non-small-cell lung cancerFeifei Liu, Christopher B Howard, Pie Huda, et al.
Cancer Letters|July 12, 2011
PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin αvβ6Jian Wang, Jingjing Wu, Jianguo Hong, et al.
Cancer Science|September 12, 2009
Norcantharidin induces HT-29 colon cancer cell apoptosis through the alphavbeta6-extracellular signal-related kinase signaling pathwayCheng Peng, Xiangqun Liu, Enyu Liu, et al.
Scientific Reports|July 1, 2022
A novel lipidic peptide with potential to promote balanced effector-regulatory T cell responsesMichael Agrez, Justyna Rzepecka, Darryl Turner, et al.
Cell & Bioscience|September 30, 2014
Integrin αvβ6 and transcriptional factor Ets-1 act as prognostic indicators in colorectal cancerCheng Peng, Huijie Gao, Zhengchuan Niu, et al.
International Journal of Cancer|June 21, 2008
Suppression of integrin alphaupsilonbeta6 by RNA interference in colon cancer cells inhibits extracellular matrix degradation through the MAPK pathwayJiayong Wang, Zhaoyang Zhang, Kesen Xu, et al.
Scientific Reports|February 6, 2016
Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling PathwayCheng Peng, Zequn Li, Zhengchuan Niu, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Australian & New Zealand Journal of Obstetrics & Gynaecology|March 31, 2026
An Immunomodulating Peptide With Potential to Counteract EndometriosisMichael Agrez
Journal for Immunotherapy of Cancer|May 20, 2026
Immune tolerance versus cancer surveillance: an ongoing challengeMichael Agrez
ANZ Journal of Surgery|September 24, 2004
Rectal cancer masquerading as an amoeboma: case report and review of the literatureMichael Agrez, Costa Karihaloo, Glenn Reeves, et al.
Biomaterials|January 10, 2025
Immune-modulating nanomedicines for enhanced drug delivery to non-small-cell lung cancerFeifei Liu, Christopher B Howard, Pie Huda, et al.
Cancer Letters|July 12, 2011
PKC promotes the migration of colon cancer cells by regulating the internalization and recycling of integrin αvβ6Jian Wang, Jingjing Wu, Jianguo Hong, et al.
Cancer Science|September 12, 2009
Norcantharidin induces HT-29 colon cancer cell apoptosis through the alphavbeta6-extracellular signal-related kinase signaling pathwayCheng Peng, Xiangqun Liu, Enyu Liu, et al.
Scientific Reports|July 1, 2022
A novel lipidic peptide with potential to promote balanced effector-regulatory T cell responsesMichael Agrez, Justyna Rzepecka, Darryl Turner, et al.
Cell & Bioscience|September 30, 2014
Integrin αvβ6 and transcriptional factor Ets-1 act as prognostic indicators in colorectal cancerCheng Peng, Huijie Gao, Zhengchuan Niu, et al.
International Journal of Cancer|June 21, 2008
Suppression of integrin alphaupsilonbeta6 by RNA interference in colon cancer cells inhibits extracellular matrix degradation through the MAPK pathwayJiayong Wang, Zhaoyang Zhang, Kesen Xu, et al.
Scientific Reports|February 6, 2016
Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling PathwayCheng Peng, Zequn Li, Zhengchuan Niu, et al.
Pageof 2